|
?:abstract
|
-
The COVID-19 pandemic caused by SARS-CoV-2 virus has caused an important health impact that has affected renal cell carcinoma management, among other urology areas The high cancellation rate of surgeries, including those related to renal cancer, will cause an inevitable healthcare overload and probably a potential negative impact on its oncological outcomes, especially in locally advanced and metastatic renal cancer Kidney cancer scenarios are quite different depending on their stage, distinguishing mainly between low priority of localized disease or high priority of locally advanced and metastatic under active treatment The unknown pandemic duration and possibly fluctuating prevalence of the virus are likely to force an adaptation in the management of renal cell carcinoma among urology and oncology departments, ideally individualized ona case-by-case basis within multidisciplinary units To this end, we present algorithms and tables regarding renal cell carcinoma management adapted to the COVID-19 period and stratified according to oncological stage, which might be useful for specialists dedicated to this uro-oncology area La pandemia COVID-19 causada por el virus SARS-CoV-2 ha provocado un importante impacto sanitario que ha afectado, entre otras areas de la urologia, al manejo del cancer renal, tanto en su ambito diagnostico como de tratamiento La elevada suspension de intervenciones quirurgicas, incluidas aquellas destinadas al tratamiento de esta patologia, ocasionarauna inevitable sobrecarga asistencial y quiza un potencial efecto deletereo sobre sus resultados oncologicos, en especial en el cancer renal localmente avanzado y en el metastasico Los escenarios clinicos del carcinoma de celulas renales son bien distintos en funcion de su estadiaje, distinguiendo principalmente entre la baja prioridad de la enfermedad localizada o la alta prioridad del localmente avanzado y el metastasico en tratamiento activo La duracionin determinada y prevalencia posiblemente oscilante de la pandemia previsiblemente obligue a adaptar el manejo del cancer renal en los servicios de urologia y oncologia, debiendo ser idealmente invidualizados segun cada caso en el seno de unidades multidisciplinares Para ello, se presentan algoritmos y tablas de manejo del cancer renal adaptadas al periodo COVID-19 y estratificados segun el estadio de la enfermedad, que puedan ser de utilidad para los especialistas dedicados a esta area de la uro-oncologia
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}